Vitura Health secures major distribution deal with MedReleaf Australia, a subsidiary of Canadian cannabis producer Aurora Cannabis. The agreement enables MedReleaf's full product range to be listed on Vitura's Canview platform, which connects approximately 4,700 Australian pharmacies. This partnership could generate up to $15 million in additional annual revenue for Vitura across its distribution channels, pending patient demand and regulatory conditions. The deal represents a significant expansion of Vitura's medicinal cannabis distribution capabilities and positions the company as a key partner in Australia's consolidating cannabis supply landscape. Vitura has demonstrated strong revenue growth over five years and continues expanding through strategic acquisitions and partnerships in the specialty healthcare sector.
Post from MarketNews_en
Log in to interact with content.